TCR2 Therapeutics
Why Robinhood?
You can watch TCRR and buy or sell other stocks, ETFs, and their options commission-free!About TCRR
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.
TCRR Key Statistics
Stock Snapshot
The current TCR2 Therapeutics(TCRR) stock price is $1.48, with a market capitalization of 58.11M. The stock trades at a price-to-earnings (P/E) ratio of -0.35.
On 2026-03-14, TCR2 Therapeutics(TCRR) stock opened at —, reached a high of —, and a low of —.
The TCR2 Therapeutics(TCRR)'s current trading volume is 0, compared to an average daily volume of 694.31K.
In the last year, TCR2 Therapeutics(TCRR) shares hit a 52-week high of $3.88 and a 52-week low of $0.82.
In the last year, TCR2 Therapeutics(TCRR) shares hit a 52-week high of $3.88 and a 52-week low of $0.82.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.